<?xml version="1.0" encoding="UTF-8"?>
<svg height="767.9" width="530.5" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.61,0.5,0.44,0.39,0.78,0.44,0.41,0.39,0.56,0.33,0.28,0.41,0.39" y="63.0" x="76.3,81.2,85.1,88.7,91.8,98.0,101.5,104.8,107.9,112.3,115.0,117.2,120.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Pharmaceutics</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="63.0" x="125.5,129.5,133.5,137.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2017</text>
  <text svgx:width="0.25" y="63.0" x="141.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5" y="63.0" x="145.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">9</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.55,0.5,0.5,0.55,0.55,0.33,0.55,0.5,0.5" y="63.0" x="149.4,151.4,153.4,157.4,161.4,491.8,495.8,499.8,501.8,506.1,508.8,510.8,514.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 48 10 of 12</text>
  <text svgx:width="0.34,0.58,0.55,0.44,0.55,0.58,0.44,0.29,0.6,0.42,0.29,0.55,0.58,0.25,0.55,0.33,0.58,0.48,0.55,0.4,0.48,0.42,0.6,0.29,0.33,0.42,0.55,0.55,0.33,0.55,0.33,0.58,0.29,0.42,0.55,0.42,0.33,0.6,0.61,0.56,0.55,0.6,0.55,0.29,0.58,0.33,0.48,0.61,0.55,0.55,0.6,0.33,0.55,0.33,0.58,0.5,0.33,0.55,0.29,0.58,0.55,0.56,0.29,0.56,0.55,0.55,0.33,0.55,0.6,0.29,0.44,0.5,0.29,0.55,0.5,0.6,0.6,0.29,0.29,0.44,0.5,0.33,0.29,0.55,0.58,0.55,0.55,0.33,0.55,0.4,0.55,0.42,0.48,0.88,0.5,0.4,0.56" y="97.8" x="97.8,101.2,107.0,109.7,114.2,119.7,125.7,130.2,133.1,139.3,143.6,146.5,152.1,158.0,160.5,163.1,166.4,172.3,177.1,179.8,183.6,188.4,192.8,198.9,201.8,205.2,209.3,212.0,217.6,220.9,223.5,226.8,232.7,235.7,239.9,242.6,246.9,250.2,256.3,262.5,268.1,270.7,276.8,282.4,285.3,291.2,294.6,299.4,305.5,308.2,313.7,319.9,323.1,325.7,329.0,335.0,340.0,343.3,345.9,348.8,354.6,357.1,362.7,365.6,371.3,376.7,379.2,382.6,388.1,394.2,397.2,401.7,406.8,409.7,412.3,417.4,423.5,429.6,432.5,435.5,440.0,445.1,448.4,451.3,456.9,462.7,465.4,470.9,474.2,476.9,480.7,486.2,490.5,495.4,504.4,509.5,513.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">In conclusion, the results of this study pointed out that in vivo topical application of rosemary</text>
  <text svgx:width="0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.55,0.33,0.4,0.55,0.88,0.55,0.56,0.48,0.29,0.55,0.56,0.48,0.58,0.29,0.44,0.29,0.48,0.42,0.55,0.42,0.58,0.55,0.83,0.48,0.61,0.55,0.5,0.55,0.58,0.56,0.61,0.4,0.5,0.33,0.29,0.58,0.56,0.55,0.48,0.33,0.33,0.48,0.44,0.33,0.55,0.33,0.58,0.5,0.33,0.55,0.4,0.48,0.88,0.5,0.4,0.56,0.5,0.55,0.29,0.56,0.55,0.29,0.58,0.44,0.4,0.48,0.5,0.42,0.48,0.61,0.55,0.6,0.6,0.55,0.58,0.55,0.4,0.55,0.42,0.48,0.88,0.5,0.4,0.56" y="111.4" x="76.5,81.4,85.7,90.0,94.9,100.8,104.1,107.1,112.2,115.0,117.7,123.3,126.2,129.1,131.8,135.2,139.0,144.6,153.4,156.2,161.8,166.7,169.6,172.3,178.0,182.9,188.8,191.8,196.3,199.2,204.1,208.3,211.0,215.3,221.3,226.8,235.3,240.1,246.2,249.0,254.0,256.7,262.6,268.2,274.4,278.5,283.5,286.9,289.8,295.7,301.3,304.0,308.9,312.1,315.5,320.3,324.8,328.1,330.8,334.1,340.0,345.1,348.4,351.0,354.8,359.7,368.7,373.8,377.8,383.4,388.5,394.1,397.1,402.7,405.4,408.3,414.2,418.7,422.6,427.4,432.5,436.8,441.7,447.8,450.5,456.7,462.8,468.3,474.1,476.9,480.7,486.2,490.5,495.4,504.4,509.5,513.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">essential oil from gel vehicles showed a hydrating effect that remarkably increased upon rosemary</text>
  <text svgx:width="0.61,0.79,0.55,0.29,0.55,0.5,0.61,0.29,0.58,0.56,0.55,0.29,0.58,0.33,0.55,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.25,0.55,0.78,0.55,0.42,0.29,0.29,0.56,0.58,0.33,0.55,0.55,0.6,0.33,0.55,0.42,0.29,0.56,0.58,0.29,0.61,0.44,0.5,0.58,0.33,0.55,0.48,0.33,0.33,0.48,0.44,0.33,0.55,0.55,0.58,0.55,0.42,0.56,0.29,0.58,0.55,0.48,0.29,0.5,0.42,0.33,0.29,0.44,0.29,0.33,0.56,0.55,0.44,0.55,0.6,0.29,0.61,0.55,0.55,0.48,0.55,0.61,0.48,0.33,0.48,0.44,0.33,0.48,0.61" y="124.9" x="76.5,82.6,90.5,92.9,95.8,101.2,106.2,112.2,115.1,120.9,126.5,128.9,131.8,137.6,140.8,146.3,148.7,151.6,154.5,160.5,163.4,169.4,171.9,177.7,182.7,188.4,193.9,199.8,204.8,208.7,212.0,214.9,219.3,222.2,226.9,231.1,233.6,236.7,244.5,246.9,251.1,254.0,256.9,262.4,268.2,271.5,273.9,279.4,285.4,288.7,291.1,295.3,298.2,303.7,309.5,312.4,318.4,322.8,327.8,333.6,336.9,339.3,344.1,347.2,350.5,355.3,359.7,363.0,365.4,370.8,376.6,379.1,383.3,388.8,391.7,397.5,400.0,404.7,407.6,412.6,416.8,420.0,422.9,427.3,430.2,433.4,439.0,441.5,445.9,451.3,457.3,460.2,466.2,468.7,474.2,479.0,481.4,487.5,492.3,495.5,500.3,504.7,507.9,512.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">EO loading into lipid nanoparticles. A slight but signiﬁcant effect on skin elasticity could be detected</text>
  <text svgx:width="0.55,0.58,0.29,0.56,0.55,0.5,0.33,0.33,0.48,0.4,0.55,0.33,0.55,0.6,0.29,0.44,0.5,0.29,0.55,0.5,0.6,0.6,0.29,0.29,0.44,0.5,0.33,0.29,0.55,0.58,0.55,0.55,0.33,0.55,0.56,0.48,0.29,0.55,0.56,0.48,0.58,0.29,0.44,0.29,0.48,0.42,0.55,0.44,0.55,0.58,0.33,0.5,0.29,0.58,0.29,0.58,0.56,0.55,0.6,0.58,0.29,0.55,0.5,0.61,0.48,0.61,0.55,0.52,0.61,0.83,0.42,0.55,0.55,0.4,0.55,0.4,0.55,0.42,0.48,0.88,0.5,0.4,0.56,0.55,0.61,0.79,0.33,0.29,0.55,0.5,0.61,0.48,0.61,0.55,0.83,0.61,0.71,0.42,0.25" y="138.4" x="76.5,81.9,87.7,90.5,96.1,98.5,103.4,106.7,109.9,114.6,118.6,121.0,124.2,129.6,135.5,138.4,142.8,147.7,150.6,153.1,158.0,163.9,169.9,172.7,175.6,180.0,184.9,188.1,191.0,196.4,202.2,204.6,210.0,213.3,215.7,221.2,225.9,228.8,231.3,236.9,241.6,247.3,250.2,254.6,257.5,262.2,266.4,268.8,273.2,278.6,284.3,287.6,292.5,295.4,301.1,304.0,309.7,315.3,317.7,323.6,329.4,332.2,337.6,342.5,348.6,353.3,359.4,361.8,367.0,373.0,381.2,385.4,387.9,393.2,397.2,399.6,403.3,408.7,412.9,417.6,426.3,431.3,435.2,440.7,443.1,449.1,456.9,460.2,463.1,468.4,473.4,479.4,484.1,490.2,492.6,500.8,506.8,513.8,518.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">only after topical application of gel vehicles containing unloaded SLNs or rosemary EO-loaded NLCs.</text>
  <text svgx:width="0.61,0.58,0.48,0.4,0.48,0.33,0.55,0.4,0.48,0.25,0.55,0.29,0.55,0.5,0.61,0.29,0.58,0.56,0.55,0.4,0.55,0.42,0.48,0.88,0.5,0.4,0.56,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.55,0.29,0.58,0.33,0.55,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.55,0.42,0.48,0.48,0.88,0.42,0.55,0.33,0.55,0.55,0.55,0.48,0.55,0.5,0.55,0.6,0.4,0.55,0.88,0.29,0.42,0.29,0.58,0.56,0.55,0.42,0.33,0.4,0.5,0.33,0.48,0.56,0.56" y="151.9" x="76.2,82.5,88.4,93.2,97.1,101.9,105.3,110.9,114.7,119.6,122.1,125.0,128.0,133.5,138.6,144.8,147.8,153.7,159.3,162.1,166.0,171.5,175.8,180.7,189.7,194.8,198.8,204.3,207.2,212.1,216.4,220.7,225.6,231.5,234.8,237.8,242.9,245.7,248.6,254.2,257.1,260.0,262.9,265.9,271.8,275.1,280.6,283.5,286.4,289.4,295.5,298.4,304.5,307.5,313.4,318.5,324.4,329.9,336.0,341.1,345.1,348.4,351.4,355.9,358.9,363.7,367.9,370.8,375.2,380.0,384.9,393.9,398.0,401.0,404.3,409.8,412.7,418.3,423.1,426.0,430.9,433.9,440.0,443.8,449.4,458.3,461.3,465.6,468.6,474.5,480.0,482.9,487.2,490.6,494.6,499.7,503.0,507.8,513.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Therefore, loading rosemary essential oil into lipid nanoparticles seems to be a promising strategy</text>
  <text svgx:width="0.33,0.55,0.55,0.29,0.88,0.6,0.4,0.55,0.56,0.48,0.55,0.29,0.33,0.42,0.55,0.33,0.55,0.6,0.29,0.44,0.5,0.29,0.55,0.55,0.48,0.58,0.48,0.61,0.33,0.42,0.55,0.5,0.58,0.61,0.55,0.33,0.55,0.4,0.55,0.61,0.48,0.42,0.29,0.56,0.58,0.29,0.58,0.56,0.55,0.33,0.55,0.6,0.29,0.44,0.5,0.29,0.55,0.33,0.55,0.4,0.88,0.6,0.29,0.5,0.33,0.29,0.55,0.58,0.42,0.55,0.33,0.55,0.4,0.55,0.33,0.58,0.48,0.55,0.33,0.4,0.48,0.5,0.33,0.88,0.48,0.58,0.33,0.55,0.55,0.33,0.55,0.44,0.6,0.33,0.5,0.58,0.48,0.55,0.6,0.42" y="165.4" x="76.5,79.8,85.3,87.8,90.7,99.6,105.7,109.4,114.9,120.6,125.4,127.9,130.9,134.2,138.3,140.9,144.2,149.7,155.7,158.7,163.1,168.2,171.0,173.6,179.1,183.9,189.8,194.6,200.7,204.0,208.2,210.8,215.8,221.6,227.7,230.3,233.6,239.1,243.1,245.6,251.7,256.5,260.8,263.7,269.3,275.2,278.1,284.0,289.6,292.1,295.3,300.8,306.9,309.8,314.3,319.3,322.2,324.7,328.1,333.6,337.5,346.4,352.5,355.4,360.5,363.7,366.7,372.2,378.0,382.2,384.8,388.1,393.6,397.6,400.1,403.4,409.2,414.0,416.5,419.8,423.6,428.4,433.5,436.7,445.6,450.4,456.3,459.6,462.1,467.6,470.8,473.4,477.9,483.9,487.2,492.2,498.1,502.9,508.4,514.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">to improve its topical beneﬁts and for designing topical formulations for the treatment of cutaneous</text>
  <text svgx:width="0.5,0.29,0.33,0.48,0.4,0.5,0.33,0.29,0.55,0.58,0.42,0.55,0.29,0.58,0.56,0.55,0.29,0.56,0.29,0.58,0.56,0.55,0.29,0.55,0.42,0.42,0.55,0.55,0.33,0.55,0.42,0.56,0.29,0.58,0.55,0.58,0.56,0.61,0.4,0.5,0.33,0.29,0.55,0.58,0.55,0.5,0.58,0.61,0.55,0.48,0.29,0.5,0.42,0.33,0.29,0.44,0.29,0.33,0.56,0.25" y="178.9" x="76.5,81.5,84.4,87.7,92.4,96.4,101.4,104.6,107.5,112.9,118.7,122.9,125.5,128.4,134.1,139.8,145.2,148.1,153.7,156.6,162.4,168.0,170.5,173.4,178.8,183.0,187.2,189.8,195.2,198.5,201.0,205.2,210.8,213.7,219.4,221.9,227.7,233.3,239.4,243.3,248.3,251.5,254.4,259.9,265.7,268.2,273.1,278.9,285.0,287.5,292.3,295.2,300.2,304.4,307.6,310.5,315.0,317.9,321.1,325.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">alterations involving loss of skin hydration and elasticity.</text>
  <text svgx:width="0.78,0.44,0.61,0.61,0.56,0.83,0.33,0.5,0.61,0.56,0.89,0.5,0.61,0.33,0.44,0.25" y="201.0" x="76.2,83.2,87.1,92.6,98.1,103.1,110.6,113.5,118.0,123.5,128.5,136.5,140.9,146.4,149.4,153.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Acknowledgments:</text>
  <text svgx:width="0.61,0.58,0.48,0.55,0.5,0.6,0.33,0.58,0.55,0.4,0.42,0.55,0.33,0.58,0.5,0.58,0.56,0.55,0.61,0.52,0.48,0.58,0.33,0.29,0.5,0.48,0.55,0.42,0.25,0.4,0.25,0.29,0.25,0.55,0.33,0.55,0.4,0.55,0.56,0.29,0.33,0.33,0.29,0.58,0.56,0.55,0.4,0.55,0.42,0.48,0.88,0.5,0.4,0.56,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.25" y="201.0" x="158.4,163.9,169.1,173.4,175.7,180.1,185.5,188.5,193.7,198.6,202.1,205.9,208.2,211.1,216.3,220.8,226.0,231.0,233.2,238.7,243.3,247.6,252.9,255.8,258.4,262.9,267.2,269.4,273.2,275.5,278.3,280.6,283.2,285.4,288.2,291.2,296.1,299.7,301.9,306.9,309.5,312.5,315.4,318.0,323.2,328.2,330.4,333.8,338.7,342.5,346.8,354.7,359.2,362.7,367.8,370.0,374.3,378.1,381.9,386.2,391.4,394.3,396.9,401.4,404.0,406.2,411.1,413.8,416.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The authors thank Exentiae s.r.l. for gifting rosemary essential oil.</text>
  <text svgx:width="0.78,0.61,0.33,0.61,0.56,0.39,0.55,0.72,0.56,0.61,0.33,0.39,0.33,0.61,0.61,0.33,0.33,0.56,0.61,0.44,0.25" y="217.1" x="76.2,83.2,88.6,91.6,97.1,102.1,105.6,110.7,117.1,122.1,127.6,130.6,134.1,137.1,142.5,148.0,151.0,154.0,159.0,164.5,168.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Author Contributions:</text>
  <text svgx:width="0.61,0.6,0.44,0.29,0.5,0.55,0.95,0.55,0.58,0.33,0.48,0.58,0.48,0.56,0.4,0.55,0.55,0.5,0.58,0.61,0.55,0.71,0.5,0.4,0.88,0.48,0.29,0.5,0.55,0.6,0.5,0.4,0.48,0.58,0.33,0.29,0.55,0.44,0.55,0.58,0.44,0.48,0.29,0.56,0.48,0.61,0.55,0.55,0.33,0.55,0.5,0.58,0.61,0.55,0.61,0.48,0.42,0.29,0.56,0.58,0.48,0.61,0.55,0.33,0.58,0.48,0.55,0.42,0.33,0.6,0.61,0.56,0.25" y="217.1" x="179.2,184.8,190.3,194.3,197.0,201.5,206.7,215.3,220.3,225.6,228.6,233.0,238.3,242.7,247.8,251.2,256.2,261.3,265.9,271.2,276.7,281.9,288.4,293.0,296.6,304.6,309.0,311.7,316.2,321.4,326.9,331.5,334.9,339.3,344.6,347.6,350.2,355.3,359.4,364.4,369.7,373.8,378.2,380.8,386.0,390.4,395.8,401.1,406.0,409.0,414.2,418.8,424.1,429.6,434.8,440.4,444.7,448.6,451.3,456.4,461.7,466.1,471.5,476.7,479.7,485.0,489.4,494.5,498.4,501.4,506.9,512.5,517.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lucia Montenegro and Carmela Parenti conceived of and designed the study;</text>
  <text svgx:width="0.61,0.6,0.44,0.29,0.5,0.55,0.95,0.55,0.58,0.33,0.48,0.58,0.48,0.56,0.4,0.55,0.55,0.6,0.48,0.4,0.33,0.55,0.4,0.88,0.48,0.61,0.55,0.33,0.58,0.48,0.55,0.48,0.52,0.6,0.48,0.4,0.29,0.88,0.48,0.58,0.33,0.5,0.29,0.55,0.6,0.4,0.55,0.44,0.48,0.61,0.6,0.4,0.48,0.42,0.25,0.55,0.61,0.55,0.4,0.48,0.29,0.29,0.5,0.55,0.6,0.5,0.42,0.56,0.6,0.29,0.58,0.6,0.44,0.44,0.29,0.25,0.55,0.67,0.29,0.33,0.5,0.55,0.61,0.6,0.4,0.58,0.5,0.33,0.6,0.4,0.29,0.25,0.55,0.52,0.5,0.58,0.33,0.29,0.58,0.5,0.55,0.71,0.58,0.29,0.48,0.44,0.58,0.29,0.55,0.25" y="227.2" x="76.5,81.9,87.3,91.2,93.7,98.2,100.4,108.8,113.6,118.7,121.6,125.8,131.0,135.2,140.1,143.4,148.4,150.5,155.8,160.0,163.5,166.5,171.3,174.8,182.6,186.8,192.3,194.4,197.3,202.5,206.8,208.9,213.1,217.7,223.0,227.2,230.7,233.3,241.1,245.3,250.5,253.4,257.8,260.4,262.6,267.9,271.2,276.0,280.0,284.2,289.6,294.9,298.2,302.5,306.2,308.5,310.7,316.0,320.9,324.2,328.4,331.0,333.6,338.1,340.2,345.6,350.0,353.7,358.7,364.0,366.6,371.7,377.0,380.9,384.9,387.4,389.7,391.9,397.8,400.3,403.2,407.7,409.9,414.5,419.8,423.3,428.4,432.9,435.7,441.1,444.6,447.1,449.4,451.6,456.2,460.6,465.8,468.6,471.2,476.3,480.8,483.0,489.3,494.4,497.0,501.2,505.1,510.3,512.8,517.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lucia Montenegro performed the experimental procedures; Lorella Pasquinucci, Rita Turnaturi, Santina Chiechio,</text>
  <text svgx:width="0.5,0.58,0.61,0.55,0.78,0.56,0.5,0.33,0.5,0.55,0.67,0.5,0.6,0.6,0.5,0.29" y="237.4" x="76.5,80.9,86.0,91.5,93.6,100.4,105.3,109.7,112.6,117.1,119.2,125.0,129.4,134.7,140.0,144.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and Agata Zappal</text>
  <text svgx:width="0.5" y="237.4" x="146.9" style="fill:rgb(0,0,0);font-family:VnURWPalladioL;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">à</text>
  <text svgx:width="0.5,0.58,0.5,0.29,0.56,0.5,0.48,0.61,0.55,0.33,0.58,0.48,0.55,0.61,0.5,0.33,0.5,0.25,0.55,0.6,0.48,0.4,0.33,0.55,0.4,0.88,0.48,0.61,0.55,0.42,0.33,0.5,0.33,0.29,0.42,0.33,0.29,0.44,0.5,0.29,0.55,0.5,0.58,0.5,0.29,0.56,0.42,0.48,0.42,0.55,0.5,0.58,0.61,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.6,0.5,0.33,0.48,0.61,0.55,0.29,0.58,0.55,0.33,0.58,0.48,0.55,0.29,0.58,0.33,0.48,0.4,0.6,0.4,0.48,0.33,0.5,0.33,0.29,0.55,0.58,0.55,0.55,0.33,0.55,0.61,0.5,0.33,0.5,0.25" y="237.4" x="153.5,157.9,163.0,167.4,170.0,174.9,179.3,183.5,188.9,191.0,193.9,199.0,203.3,205.4,210.8,215.2,218.0,222.4,224.7,226.8,232.1,236.3,239.8,242.7,247.5,251.0,258.7,262.9,268.4,270.5,274.2,277.1,281.5,284.3,286.9,290.6,293.5,296.1,300.0,304.3,306.9,309.1,313.5,318.6,323.0,325.6,330.4,334.2,338.4,342.1,344.3,348.7,353.8,359.3,361.4,366.6,371.0,374.5,377.4,379.9,383.8,386.4,391.7,396.1,398.9,403.1,408.6,410.7,413.2,418.4,420.6,423.4,428.5,432.8,434.9,437.5,442.6,445.5,449.7,453.1,458.4,461.7,466.0,468.8,473.2,476.1,478.6,483.4,488.6,490.7,495.5,498.5,500.6,506.0,510.4,513.3,517.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">analyzed the data, performed statistical analyses and participated in the interpretation of data;</text>
  <text svgx:width="0.61,0.6,0.44,0.29,0.5,0.55,0.95,0.55,0.58,0.33,0.48,0.58,0.48,0.56,0.4,0.55,0.55,0.5,0.58,0.61,0.55,0.71,0.5,0.4,0.88,0.48,0.29,0.5,0.55,0.6,0.5,0.4,0.48,0.58,0.33,0.29,0.55,0.44,0.55,0.58,0.33,0.4,0.29,0.55,0.6,0.33,0.48,0.61,0.55,0.88,0.5,0.33,0.48,0.4,0.29,0.5,0.29,0.42,0.55,0.5,0.58,0.61,0.55,0.5,0.58,0.5,0.29,0.56,0.42,0.29,0.42,0.55,0.33,0.55,0.55,0.29,0.42,0.25,0.55,0.61,0.6,0.44,0.29,0.5,0.55,0.95,0.55,0.58,0.33,0.48,0.58,0.48,0.56,0.4,0.55,0.55,0.83,0.4,0.55,0.33,0.48,0.55,0.33,0.58,0.48" y="247.5" x="76.5,82.1,87.6,91.7,94.4,98.8,101.2,109.8,114.8,120.1,123.1,127.5,132.8,137.2,142.3,145.7,150.7,152.9,157.5,162.8,168.3,170.7,177.1,181.7,185.3,193.4,197.8,200.5,204.9,207.3,212.8,217.4,220.8,225.2,230.5,233.5,236.1,238.4,242.4,247.4,252.7,255.7,259.3,262.0,267.1,272.6,275.6,279.9,285.4,287.8,295.8,300.4,303.4,307.8,311.4,314.0,318.6,321.3,325.0,327.4,332.0,337.3,342.8,345.1,349.7,355.0,359.6,362.2,367.3,371.2,373.8,377.6,380.0,382.9,387.9,392.9,395.6,399.5,401.7,404.0,409.6,415.1,419.1,421.8,426.3,428.6,437.3,442.2,447.6,450.5,454.9,460.3,464.6,469.7,473.2,478.1,480.4,488.0,491.5,496.5,499.4,503.7,506.1,509.0,514.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lucia Montenegro and Carmela Parenti contributed materials and analysis tools; Lucia Montenegro wrote the</text>
  <text svgx:width="0.88,0.5,0.58,0.6,0.42,0.44,0.4,0.29,0.6,0.33,0.25,0.55,0.78,0.29,0.29,0.55,0.5,0.6,0.33,0.58,0.55,0.4,0.42,0.55,0.4,0.48,0.5,0.61,0.55,0.5,0.58,0.61,0.55,0.5,0.6,0.6,0.4,0.55,0.56,0.48,0.61,0.55,0.33,0.58,0.48,0.55,0.88,0.5,0.58,0.6,0.42,0.44,0.4,0.29,0.6,0.33,0.25" y="257.6" x="76.5,84.5,88.9,94.2,99.6,103.4,107.3,110.9,113.5,118.9,121.8,124.0,126.8,133.8,136.4,139.0,141.3,145.7,151.2,154.1,159.3,164.2,167.7,171.5,173.8,177.2,181.5,185.9,191.4,193.7,198.1,203.4,208.8,211.1,215.6,220.9,226.3,229.7,234.6,239.7,244.0,249.4,251.7,254.6,259.8,264.1,266.4,274.3,278.8,284.0,289.4,293.2,297.2,300.7,303.3,308.7,311.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">manuscript. All authors read and approved the manuscript.</text>
  <text svgx:width="0.72,0.56,0.61,0.61,0.33,0.44,0.33,0.44,0.55,0.56,0.39,0.55,0.39,0.61,0.33,0.5,0.39,0.5,0.44,0.33,0.25" y="273.7" x="76.5,83.0,88.0,93.5,99.0,101.9,105.9,108.9,112.9,115.1,120.1,123.6,125.8,129.3,134.8,137.8,142.3,145.8,150.2,154.2,157.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Conﬂicts of Interest:</text>
  <text svgx:width="0.61,0.58,0.48,0.55,0.5,0.6,0.33,0.58,0.55,0.4,0.42,0.55,0.61,0.48,0.44,0.29,0.5,0.4,0.48,0.55,0.58,0.55,0.55,0.44,0.55,0.58,0.61,0.29,0.44,0.33,0.55,0.55,0.33,0.55,0.29,0.58,0.33,0.48,0.4,0.48,0.42,0.33,0.25" y="273.7" x="162.2,167.7,173.0,177.3,179.5,184.0,189.4,192.3,197.5,202.4,206.0,209.7,212.0,217.5,221.8,225.8,228.4,232.8,236.2,240.5,242.8,248.0,252.9,255.1,259.1,264.0,269.2,274.7,277.3,281.3,284.2,286.4,291.3,294.3,296.5,299.2,304.4,307.3,311.6,315.0,319.3,323.1,326.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">The authors declare no conﬂict of interest.</text>
  <text svgx:width="0.72,0.5,0.39,0.5,0.39,0.5,0.61,0.44,0.5,0.44" y="300.0" x="76.5,83.7,88.7,92.6,97.6,101.4,106.4,112.5,116.9,121.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:10.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">References</text>
  <text svgx:width="0.5,0.25,0.55,0.52,0.5,0.5,0.61,0.25,0.55,0.83,0.25,0.67,0.25,0.25,0.55,0.95,0.6,0.29,0.29,0.48,0.4,0.25,0.55,0.71,0.25,0.77,0.25,0.25,0.55,0.61,0.55,0.55,0.42,0.33,0.48,0.29,0.58,0.25,0.55,0.78,0.25,0.55,0.95,0.5,0.23,0.55,0.4,0.55,0.55,0.29,0.55,0.5,0.44,0.33,0.29,0.56,0.29,0.33,0.29,0.48,0.42,0.55,0.5,0.58,0.61,0.55,0.88,0.48,0.44,0.58,0.5,0.58,0.29,0.42,0.88,0.55,0.33,0.55,0.5,0.44,0.33,0.29,0.55,0.58,0.55,0.55,0.33,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,0.55,0.5,0.58,0.61,0.55,0.33,0.58,0.48,0.29,0.4" y="318.9" x="76.5,81.0,83.3,98.1,102.7,107.2,111.6,117.0,119.3,121.5,128.9,131.1,136.1,138.3,140.5,142.7,151.2,156.5,159.1,161.7,166.0,168.8,171.0,173.3,179.6,181.8,188.7,190.9,193.2,195.4,200.8,205.7,210.6,214.3,217.2,221.5,224.1,229.3,231.5,233.7,240.7,242.9,245.1,253.5,258.0,260.1,264.9,268.5,270.7,275.6,278.2,283.0,287.5,291.4,294.3,296.9,301.9,304.5,307.4,310.0,314.3,318.0,320.3,324.7,329.9,335.4,337.6,345.4,349.7,353.6,358.8,363.3,368.4,371.0,374.8,384.9,389.7,392.7,394.9,399.4,403.3,406.2,408.8,413.7,418.9,421.1,426.0,428.9,431.1,435.4,439.2,443.0,447.2,452.4,455.3,457.9,462.3,464.9,467.1,472.0,474.6,477.2,480.9,483.2,487.6,492.8,498.3,500.5,503.4,508.6,512.8,515.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1. Saad, N.Y.; Muller, C.D.; Lobstein, A. Major bioactivities and mechanismof action of essential oils and their</text>
  <text svgx:width="0.44,0.55,0.88,0.6,0.55,0.58,0.48,0.58,0.33,0.42,0.25" y="331.8" x="98.1,102.0,106.9,114.8,120.2,125.1,130.3,134.6,139.9,142.8,146.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">components.</text>
  <text svgx:width="0.56,0.28,0.44,0.5,0.44,0.56,0.39,0.25,0.55,0.56,0.39,0.44,0.5,0.39,0.25,0.55,0.33,0.25" y="331.8" x="151.6,156.6,159.1,163.1,167.5,171.5,176.5,179.3,181.6,184.4,189.3,192.8,196.8,201.3,204.1,206.4,209.1,212.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Flavour. Fragr. J.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="331.8" x="216.6,221.1,225.6,230.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2013</text>
  <text svgx:width="0.25" y="331.8" x="234.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="331.8" x="239.0,243.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">28</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="331.8" x="248.0,250.2,252.5,257.0,261.4,265.9,270.4,274.9,279.4,283.9,286.1,288.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 269–279. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="331.8" x="291.9,298.2,301.6,306.5,310.3,314.1,320.1,324.4" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="331.8" x="327.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.78,0.61,0.55,0.4,0.23,0.5,0.58,0.25,0.55,0.61,0.25,0.25,0.55,0.61,0.6,0.44,0.58,0.55,0.5,0.6,0.48,0.4,0.25,0.55,0.76,0.25,0.55,0.61,0.29,0.55,0.29,0.55,0.56,0.29,0.44,0.5,0.29,0.55,0.6,0.4,0.55,0.6,0.48,0.4,0.33,0.29,0.48,0.42,0.55,0.55,0.33,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,0.25,0.55,0.78,0.58,0.55,0.6,0.6,0.61,0.5,0.33,0.48,0.61,0.55,0.4,0.48,0.56,0.29,0.48,0.83,0.25" y="344.8" x="76.5,81.0,83.3,98.1,105.0,110.5,115.3,118.9,120.9,125.4,130.6,132.9,135.1,140.5,142.8,145.0,147.2,152.7,158.1,162.0,167.2,172.2,176.6,182.0,186.3,189.2,191.4,193.6,200.4,202.7,204.9,210.4,213.0,217.8,220.4,225.3,230.3,232.9,236.8,241.3,243.9,246.1,251.5,254.9,259.8,265.1,269.4,272.9,275.8,278.4,282.7,286.5,288.7,293.6,296.6,298.8,303.1,306.9,310.7,314.9,320.1,323.1,325.6,330.1,332.7,334.9,339.8,342.4,345.0,348.8,351.0,353.8,360.8,366.0,368.2,373.6,378.9,384.4,388.9,391.8,396.1,401.5,403.7,407.1,411.4,416.4,419.0,423.3,429.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2. Adorjan, B.; Buchbauer, G. Biological properties of essential oils: An updated review.</text>
  <text svgx:width="0.56,0.28,0.44,0.5,0.44,0.56,0.39,0.25,0.55,0.56,0.39,0.44,0.5,0.39,0.25,0.55,0.33,0.25" y="344.8" x="434.9,439.9,442.4,446.4,450.8,454.8,459.7,462.6,464.8,467.6,472.5,476.0,480.0,484.4,487.2,489.5,492.3,495.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Flavour. Fragr. J.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="344.8" x="499.7,504.2,508.7,513.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2010</text>
  <text svgx:width="0.25" y="344.8" x="517.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="357.7" x="97.8,102.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">25</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="357.7" x="106.8,109.0,111.3,115.8,120.2,124.7,129.2,133.7,138.2,142.7,144.9,147.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 407–426. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="357.7" x="150.7,157.0,160.4,165.3,169.1,172.9,178.9,183.2" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="357.7" x="186.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.61,0.5,0.56,0.56,0.5,0.29,0.29,0.25,0.55,0.56,0.25,0.25,0.55,0.78,0.56,0.48,0.4,0.55,0.48,0.44,0.56,0.25,0.55,0.52,0.25,0.25,0.55,0.78,0.56,0.48,0.4,0.55,0.48,0.44,0.56,0.25,0.55,0.77,0.25,0.25,0.55,0.34,0.61,0.5,0.55,0.88,0.5,0.4,0.25,0.55,0.95,0.25,0.55,0.61,0.29,0.55,0.29,0.55,0.56,0.29,0.44,0.5,0.29,0.55,0.48,0.33,0.33,0.48,0.44,0.33,0.42,0.55,0.55,0.33,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,1.0,0.78,0.55,0.4,0.48,0.56,0.29,0.48,0.83,0.25" y="370.6" x="76.5,81.0,83.3,98.1,103.6,108.2,113.3,118.4,123.0,125.6,128.3,130.5,135.2,139.5,141.8,144.0,149.9,156.2,161.4,165.8,169.4,174.5,178.8,182.9,188.0,190.2,194.9,199.7,202.0,204.3,210.2,216.5,221.6,226.0,229.6,234.7,239.1,243.1,248.2,250.5,255.2,262.3,264.5,266.8,272.7,275.8,281.4,285.9,290.9,299.0,303.6,306.5,308.8,313.5,322.1,324.4,329.1,334.7,337.3,342.3,345.0,350.0,355.1,357.7,361.8,366.4,369.0,373.7,378.1,381.0,384.0,388.4,392.4,395.4,399.2,404.0,409.0,411.9,416.7,421.1,424.9,428.8,433.2,438.5,441.5,444.2,448.7,451.3,456.1,461.1,463.7,466.4,470.3,479.4,486.4,491.2,494.6,499.0,504.2,506.8,511.2,518.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">3. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review.</text>
  <text svgx:width="0.56,0.44,0.44,0.5,0.55,0.67,0.5,0.39,0.78,0.25,0.55,0.61,0.44,0.5,0.28,0.41,0.44,0.28,0.25" y="383.5" x="97.8,102.8,106.8,110.7,115.2,117.5,123.5,127.9,131.4,138.4,140.6,142.9,147.4,151.3,155.8,158.3,162.0,166.0,168.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Food Chem. Toxicol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="383.5" x="173.5,177.9,182.4,186.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2008</text>
  <text svgx:width="0.25" y="383.5" x="191.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="383.5" x="195.9,200.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">46</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="383.5" x="204.8,207.1,209.3,213.8,218.3,222.8,227.3,231.7,236.2,240.7,243.0,245.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 446–475. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="383.5" x="248.7,255.1,258.5,263.4,267.2,271.0,276.9,281.2" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33,0.55,0.33" y="383.5" x="284.2,287.2,289.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">] [</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="383.5" x="292.4,297.9,303.3,308.2,316.7,321.0" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="383.5" x="326.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.56,0.4,0.5,0.58,0.5,0.25,0.55,0.71,0.25,0.95,0.25,0.55,0.61,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.55,0.4,0.48,0.42,0.48,0.5,0.4,0.44,0.58,0.25,0.55,0.6,0.5,0.42,0.33,0.25,0.55,0.6,0.4,0.48,0.42,0.48,0.58,0.33,0.55,0.5,0.58,0.61,0.55,0.33,0.6,0.33,0.6,0.4,0.48,0.25" y="396.4" x="76.5,81.0,83.3,98.1,103.0,106.6,111.1,116.3,120.8,123.0,125.2,131.6,133.8,142.3,144.6,146.8,152.3,156.1,159.9,164.2,169.4,172.3,174.9,179.4,182.0,184.3,189.2,191.8,194.4,196.6,200.0,204.3,208.1,212.4,216.9,220.3,224.2,229.5,231.7,234.5,239.9,244.4,248.2,251.1,253.3,255.6,261.0,264.4,268.6,272.5,276.7,282.0,284.9,287.1,291.6,296.8,302.3,304.6,307.5,312.9,315.9,321.3,324.7,328.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">4. Franz, C.M. Essential oil research: Past, present and future.</text>
  <text svgx:width="0.56,0.28,0.44,0.5,0.44,0.56,0.39,0.25,0.55,0.56,0.39,0.44,0.5,0.39,0.25,0.55,0.33,0.25" y="396.4" x="334.0,339.0,341.4,345.4,349.9,353.9,358.9,361.7,363.9,366.7,371.7,375.2,379.2,383.7,386.5,388.7,391.5,394.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Flavour. Fragr. J.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="396.4" x="399.0,403.5,407.9,412.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2010</text>
  <text svgx:width="0.25" y="396.4" x="416.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="396.4" x="421.4,425.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">25</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="396.4" x="430.4,432.6,434.8,439.3,443.8,448.3,452.8,457.3,461.7,466.2,468.5,471.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 112–113. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="396.4" x="474.2,480.6,484.0,488.9,492.7,496.5,502.5,506.8" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="396.4" x="509.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.78,0.58,0.33,0.58,0.55,0.58,0.56,0.25,0.55,0.73,0.25,0.6,0.25,0.25,0.55,0.77,0.48,0.55,0.29,0.6,0.33,0.52,0.55,0.55,0.55,0.56,0.6,0.58,0.25,0.55,0.52,0.25,0.78,0.25,0.25,0.55,0.52,0.5,0.29,0.48,0.58,0.25,0.55,0.95,0.25,0.78,0.25,0.55,0.71,0.55,0.88,0.6,0.4,0.48,0.58,0.48,0.58,0.42,0.29,0.56,0.48,0.55,0.5,0.42,0.42,0.48,0.42,0.42,0.88,0.48,0.58,0.33,0.55,0.55,0.33,0.55,0.5,0.58,0.33,0.29,0.55,0.52,0.29,0.61,0.5,0.58,0.33,0.55,0.5,0.44,0.33,0.29,0.56,0.29,0.33,0.56,0.55,0.55,0.33" y="409.3" x="76.5,81.0,83.3,98.1,105.2,110.5,113.5,118.8,123.8,129.1,133.2,135.4,138.6,145.2,147.5,151.9,154.1,156.4,159.9,167.0,171.4,176.4,179.0,184.6,187.6,192.4,197.4,202.4,207.4,212.5,218.0,223.4,225.6,228.7,233.5,235.8,242.9,245.2,247.5,251.0,255.8,260.4,263.0,267.4,272.7,275.0,278.1,286.8,289.0,296.2,298.4,301.5,308.0,313.0,321.1,326.6,330.0,334.4,339.7,344.1,349.4,353.3,356.0,361.1,365.4,368.6,373.2,377.0,380.9,385.3,389.2,393.0,401.1,405.5,410.8,413.8,416.9,421.9,424.8,428.0,432.6,437.9,440.9,443.5,448.5,453.3,455.9,461.5,466.1,471.4,474.4,477.5,482.0,486.1,489.1,491.7,496.9,499.6,502.5,507.6,510.7,515.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">5. Anthony, K.P.; Deolu-Sobogun, S.A.; Saleh, M.A. Comprehensive assessment of antioxidant activity of</text>
  <text svgx:width="0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,0.25" y="422.2" x="98.1,102.3,106.1,109.9,114.2,119.5,122.4,125.0,129.5,132.1,134.3,139.2,141.8,144.4,148.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">essential oils.</text>
  <text svgx:width="0.33,0.25,0.55,0.56,0.44,0.44,0.5,0.55,0.56,0.41,0.28,0.25" y="422.2" x="153.3,156.3,158.5,160.7,165.7,169.7,173.7,178.2,180.4,185.4,189.0,191.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">J. Food Sci.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="422.2" x="196.6,201.0,205.5,210.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2012</text>
  <text svgx:width="0.25" y="422.2" x="214.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="422.2" x="219.0,223.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">77</text>
  <text svgx:width="0.25,0.55,0.71,0.5,0.5,0.5,0.5,0.71,0.5,0.5,0.5,0.25,0.55,0.33" y="422.2" x="227.9,230.2,232.4,238.8,243.3,247.7,252.2,256.7,263.1,267.6,272.0,276.5,278.8,281.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, C839–C843. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="422.2" x="284.5,290.9,294.3,299.2,303.0,306.8,312.7,317.0" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33,0.55,0.33" y="422.2" x="320.0,323.0,325.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">] [</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="422.2" x="328.2,333.7,339.1,344.0,352.5,356.8" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="422.2" x="362.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.61,0.61,0.4,0.29,0.42,0.25,0.55,0.78,0.25,0.61,0.25,0.55,0.6,0.58,0.5,0.4,0.88,0.5,0.44,0.48,0.6,0.33,0.29,0.44,0.5,0.29,0.55,0.5,0.58,0.61,0.55,0.33,0.58,0.48,0.4,0.5,0.6,0.48,0.6,0.33,0.29,0.44,0.55,0.6,0.55,0.33,0.48,0.58,0.33,0.29,0.5,0.29,0.42,0.55,0.55,0.33,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,0.55,0.5,0.58,0.61,0.55,0.33,0.58,0.48,0.29,0.4,0.55,0.29,0.58,0.61,0.29,0.56,0.29,0.61,0.6,0.5,0.29,0.55,0.56,0.55,0.29,0.5,0.33,0.29,0.29,0.48" y="435.1" x="76.5,81.0,83.3,98.1,103.6,109.2,112.8,115.5,119.4,121.6,126.0,133.1,135.4,141.0,143.2,147.6,153.1,158.4,163.0,166.6,174.7,179.3,183.3,187.7,193.2,196.2,198.9,202.9,207.5,210.1,214.5,219.1,224.4,229.9,234.3,237.3,242.6,247.0,250.6,255.2,260.7,265.1,270.6,273.6,276.2,280.2,284.6,290.1,295.1,298.1,302.5,307.8,310.8,313.4,318.0,320.7,324.4,328.9,333.9,336.8,341.3,345.6,349.5,353.4,357.8,363.1,366.1,368.7,373.3,375.9,380.3,385.3,388.0,390.6,394.4,398.8,403.4,408.7,414.2,418.6,421.6,426.9,431.3,434.0,437.6,441.9,444.6,449.9,455.5,458.2,463.3,466.0,471.6,477.1,481.7,484.3,488.7,493.8,498.8,501.5,506.1,509.0,511.7,514.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">6. Edris, A.E. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile</text>
  <text svgx:width="0.44,0.55,0.58,0.42,0.33,0.29,0.33,0.6,0.48,0.58,0.33,0.42,0.25,0.55,0.78,0.55,0.4,0.48,0.56,0.29,0.48,0.83,0.25" y="448.0" x="98.1,102.0,106.9,112.1,115.9,118.9,121.5,124.4,129.8,134.1,139.3,142.2,146.0,148.3,151.1,158.1,160.3,163.7,168.0,173.0,175.6,179.9,186.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">constituents: A review.</text>
  <text svgx:width="0.61,0.5,0.5,0.33,0.44,0.33,0.5,0.39,0.39,0.25,0.55,0.67,0.39,0.39,0.25" y="448.0" x="191.6,197.1,201.6,206.0,209.0,213.0,216.0,220.5,224.0,226.8,229.0,231.8,237.8,241.3,244.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Phytother. Res.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="448.0" x="249.8,254.3,258.8,263.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007</text>
  <text svgx:width="0.25" y="448.0" x="267.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="448.0" x="272.2,276.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">21</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="448.0" x="281.2,283.4,285.7,290.1,294.6,299.1,303.6,308.1,312.6,317.0,319.3,322.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 308–323. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="448.0" x="325.1,331.4,334.8,339.7,343.5,347.3,353.3,357.6" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33,0.55,0.33" y="448.0" x="360.6,363.5,365.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">] [</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="448.0" x="368.8,374.2,379.6,384.6,393.0,397.3" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="448.0" x="402.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.67,0.5,0.6,0.33,0.25,0.55,0.33,0.25,0.52,0.25,0.25,0.55,0.73,0.5,0.4,0.6,0.6,0.6,0.5,0.56,0.29,0.29,0.25,0.55,0.52,0.25,0.95,0.25,0.55,0.78,0.55,0.42,0.33,0.5,0.33,0.6,0.42,0.55,0.4,0.48,0.56,0.29,0.48,0.83,0.55,0.55,0.58,0.55,0.33,0.58,0.48,0.55,0.88,0.48,0.61,0.29,0.44,0.29,0.58,0.5,0.29,0.55,0.6,0.4,0.55,0.6,0.48,0.4,0.33,0.29,0.48,0.42,0.55,0.55,0.33,0.55,0.48,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,0.25" y="461.0" x="76.5,81.0,83.3,98.1,104.2,108.7,114.2,117.2,119.5,121.9,125.0,127.3,132.1,134.3,136.6,139.1,145.8,150.3,153.9,159.4,164.9,170.4,175.0,180.0,182.7,185.4,187.6,190.1,194.9,197.1,205.8,208.0,210.5,217.5,220.0,223.9,226.9,231.5,234.4,239.9,243.7,246.2,249.7,254.1,259.2,261.9,266.3,273.7,276.3,281.3,286.5,289.0,292.0,297.3,301.6,304.1,312.2,316.6,322.2,324.8,328.9,331.6,336.9,341.4,344.0,346.5,352.0,355.5,360.5,366.0,370.3,373.9,376.9,379.6,384.0,387.7,390.3,395.3,398.2,400.7,405.1,409.0,412.8,417.2,422.5,425.5,428.2,432.8,435.4,437.8,442.8,445.5,448.1,452.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">7. Raut, J.S.; Karuppayil, S.M. A status review on the medicinal properties of essential oils.</text>
  <text svgx:width="0.33,0.56,0.5,0.25,0.55,0.67,0.39,0.44,0.5,0.39,0.55,0.61,0.39,0.44,0.5,0.25" y="461.0" x="457.6,460.6,465.7,470.3,472.5,475.9,482.0,485.4,489.4,494.0,497.5,500.0,505.5,508.9,513.0,517.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Ind. Crops Prod.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="473.9" x="98.1,102.5,107.0,111.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2014</text>
  <text svgx:width="0.25" y="473.9" x="116.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="473.9" x="120.5,124.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">62</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="473.9" x="129.4,131.7,133.9,138.4,142.9,147.4,151.8,156.3,160.8,165.3,167.5,170.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 250–264. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="473.9" x="173.3,179.7,183.0,187.9,191.7,195.5,201.5,205.8" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="473.9" x="208.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.52,0.44,0.58,0.83,0.48,0.29,0.56,0.56,0.48,0.4,0.33,0.25,0.55,0.78,0.25,0.25,0.55,0.71,0.5,0.4,0.29,0.48,0.25,0.55,0.67,0.25,0.25,0.55,0.52,0.44,0.58,0.29,0.48,0.55,0.48,0.4,0.25,0.55,0.78,0.25,0.55,0.71,0.55,0.58,0.56,0.48,0.58,0.33,0.29,0.55,0.58,0.5,0.29,0.55,0.5,0.58,0.61,0.55,0.5,0.29,0.33,0.48,0.4,0.58,0.5,0.33,0.29,0.56,0.48,0.55,0.6,0.4,0.55,0.44,0.48,0.42,0.42,0.48,0.42,0.55,0.33,0.55,0.4,0.55,0.42,0.6,0.29,0.44,0.48,0.55,0.6,0.4,0.55,0.61,0.6,0.44,0.33,0.29,0.55,0.58,1.0,0.78" y="486.8" x="76.5,81.0,83.3,98.1,102.9,106.9,112.2,119.9,124.2,126.9,132.0,137.1,141.5,145.1,148.1,150.3,152.9,160.1,162.3,164.6,167.4,173.9,178.5,182.1,184.7,189.1,191.4,194.0,200.1,202.4,204.6,207.5,212.3,216.3,221.7,224.3,228.7,233.8,238.1,241.1,243.3,246.0,253.1,255.3,258.0,264.5,269.5,274.8,279.9,284.3,289.7,292.6,295.3,300.3,305.6,310.2,312.8,315.5,320.0,325.3,330.8,333.5,338.1,340.8,343.8,348.1,351.7,357.1,361.6,364.6,367.3,372.4,376.8,379.4,384.9,388.4,393.4,397.4,401.8,405.7,409.6,414.0,417.7,420.4,423.5,428.5,432.1,434.7,438.6,444.1,446.7,450.8,455.1,457.8,463.3,466.7,471.7,477.3,482.8,486.9,489.9,492.5,497.5,502.8,512.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">8. Schweiggert, U.; Carle, R.; Schieber, A. Conventional and alternative processes for spice production—A</text>
  <text svgx:width="0.4,0.48,0.56,0.29,0.48,0.83,0.25" y="499.7" x="98.1,101.4,105.7,110.8,113.4,117.7,124.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">review.</text>
  <text svgx:width="0.61,0.39,0.39,0.56,0.5,0.39,0.55,0.56,0.44,0.44,0.5,0.55,0.56,0.41,0.28,0.25,0.55,0.61,0.39,0.41,0.5,0.56,0.44,0.28,0.25" y="499.7" x="129.4,133.9,137.2,140.7,145.7,150.1,153.6,155.9,160.9,164.8,168.8,173.3,175.5,180.5,184.2,186.7,188.9,191.7,196.2,199.7,203.3,207.8,212.8,216.8,219.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Trends Food Sci. Technol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="499.7" x="224.3,228.8,233.2,237.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007</text>
  <text svgx:width="0.25" y="499.7" x="242.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="499.7" x="246.7,251.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">18</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="499.7" x="255.7,257.9,260.1,264.6,269.1,273.6,278.1,282.6,287.0,291.5,293.8,296.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 260–268. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="499.7" x="299.5,305.9,309.3,314.2,318.0,321.8,327.8,332.0" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="499.7" x="335.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.25,0.55,0.71,0.58,0.4,0.29,0.42,0.33,0.48,0.58,0.42,0.42,0.55,0.58,0.25,0.55,0.33,0.25,0.61,0.25,0.25,0.55,0.56,0.55,0.4,0.42,0.42,0.33,0.4,0.55,0.88,0.25,0.55,0.6,0.25,0.25,0.55,1.0,0.48,0.58,0.58,0.55,0.48,0.4,0.56,0.25,0.55,0.78,0.25,0.95,0.25,0.25,0.55,0.73,0.5,0.4,0.29,0.55,0.48,0.4,0.56,0.25,0.55,0.78,0.25,0.61,0.25,0.25,0.55,0.95,0.5,0.33,0.6,0.4,0.5,0.25,0.55,0.95,0.25,0.55,0.78,0.29,0.4,0.55,0.55,0.52,0.29,0.61,0.5,0.33,0.29,0.55,0.58,0.55,0.29,0.58,0.44,0.4,0.48,0.5,0.42,0.48,0.42,0.55,0.42,0.56,0.29,0.58" y="512.6" x="76.5,81.0,83.3,98.1,104.5,109.8,113.4,116.0,119.9,122.8,127.2,132.5,136.3,140.2,145.1,150.4,152.6,154.9,157.9,160.2,165.8,168.0,170.3,172.5,177.6,182.6,186.1,190.0,193.8,196.8,200.4,205.4,213.4,215.6,217.9,222.2,224.5,226.7,229.0,237.3,241.6,246.9,252.2,257.2,261.6,265.0,270.0,272.3,274.5,281.6,283.9,292.5,294.7,297.0,299.3,305.9,310.4,314.0,316.6,321.6,326.0,329.4,334.5,336.7,339.0,346.1,348.3,353.2,355.5,357.7,360.0,368.6,373.1,376.1,381.6,385.2,389.7,391.9,394.2,402.8,405.1,407.3,414.4,417.0,420.6,422.9,427.8,432.5,435.2,440.7,445.2,448.2,450.9,455.8,461.0,463.3,466.0,471.3,475.3,478.7,483.1,487.6,491.5,495.8,499.6,501.9,505.8,510.8,513.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">9. Christensson, J.B.; Forsström, P.; Wennberg, A.M.; Karlberg, A.T.; Matura, M. Air oxidation increases skin</text>
  <text svgx:width="0.29,0.4,0.4,0.29,0.33,0.5,0.33,0.29,0.55,0.58,0.55,0.33,0.4,0.55,0.88,0.33,0.4,0.5,0.56,0.4,0.5,0.58,0.44,0.48,0.55,0.33,0.48,0.4,0.6,0.48,0.58,0.48,0.42,0.25" y="525.5" x="98.1,100.7,104.2,107.7,110.4,113.3,117.8,120.7,123.3,128.2,133.4,135.6,138.6,142.0,146.9,157.1,160.1,163.6,168.1,173.1,176.6,181.1,186.3,190.3,194.6,196.8,199.7,204.0,207.6,213.0,217.3,222.5,226.8,230.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">irritation fromfragrance terpenes.</text>
  <text svgx:width="0.67,0.44,0.56,0.33,0.44,0.41,0.33,0.55,0.78,0.39,0.39,0.78,0.44,0.33,0.25" y="525.5" x="235.6,241.6,245.6,250.5,253.5,257.5,261.2,264.1,266.4,273.4,276.9,280.3,287.3,291.3,294.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Contact Dermat.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="525.5" x="299.3,303.8,308.3,312.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2009</text>
  <text svgx:width="0.25" y="525.5" x="317.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="525.5" x="321.7,326.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">60</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="525.5" x="330.7,332.9,335.2,339.7,344.1,348.6,353.1,357.6,359.8,362.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 32–40. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="525.5" x="365.6,372.0,375.3,380.2,384.0,387.8,393.8,398.1" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33,0.55,0.33" y="525.5" x="401.1,404.1,406.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">] [</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="525.5" x="409.3,414.7,420.1,425.1,433.6,437.9" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="525.5" x="443.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.77,0.29,0.56,0.56,0.55,0.56,0.29,0.44,0.25,0.55,0.95,0.25,0.25,0.55,0.6,0.48,0.5,0.42,0.48,0.25,0.55,0.71,0.25,0.73,0.25,0.25,0.55,0.76,0.48,0.4,0.55,0.48,0.4,0.29,0.44,0.56,0.25,0.55,0.76,0.25,0.56,0.25,0.25,0.55,0.61,0.5,0.42,0.56,0.48,0.33,0.33,0.48,0.4,0.25,0.55,0.77,0.25,0.78,0.25,0.55,0.83,0.5,0.6,0.33,0.48,0.58,0.33,0.6,0.4,0.55,0.33,0.48,0.29,0.58,0.55,0.55,0.29,0.58,0.61,0.29,0.58,0.56,0.25,0.55,0.56,0.4,0.55,0.88,0.33,0.58,0.48,0.55,0.4,0.56,0.55,0.33,0.55,0.55,0.6,0.4,0.5,0.44,0.33,0.29,0.44,0.5,0.29" y="538.4" x="76.5,81.0,85.5,87.7,98.1,104.9,107.5,112.5,117.5,122.3,127.3,129.9,133.8,136.1,138.3,146.7,148.9,151.2,153.4,158.8,163.0,167.5,171.2,175.5,177.7,179.9,186.2,188.5,194.9,197.1,199.4,201.6,208.4,212.6,216.1,221.0,225.3,228.8,231.4,235.3,240.2,242.5,244.7,251.5,253.7,257.8,260.0,262.3,264.5,269.9,274.4,278.1,283.1,287.3,290.2,293.1,297.4,300.2,302.5,304.7,311.5,313.8,320.7,322.9,325.1,332.5,337.0,342.3,345.2,349.4,354.6,357.6,362.9,366.3,371.1,374.0,378.2,380.8,386.0,388.2,393.1,395.7,400.9,406.3,408.9,414.1,419.0,421.2,424.0,429.0,432.3,437.2,447.2,450.1,455.3,459.6,464.4,467.9,472.9,475.1,478.0,482.9,485.1,490.4,493.9,498.4,502.3,505.2,507.8,511.7,516.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">10. Divkovic, M.; Pease, C.K.; Gerberick, G.F.; Basketter, D.A. Hapten-protein binding: Fromtheory to practical</text>
  <text svgx:width="0.5,0.6,0.6,0.29,0.29,0.44,0.5,0.33,0.29,0.55,0.58,0.55,0.29,0.58,0.55,0.33,0.58,0.48,0.55,0.29,0.58,0.55,0.56,0.29,0.33,0.4,0.55,0.55,0.6,0.4,0.48,0.61,0.29,0.44,0.33,0.29,0.55,0.58,0.55,0.55,0.33,0.55,0.42,0.56,0.29,0.58,0.55,0.42,0.48,0.58,0.42,0.29,0.33,0.29,0.5,0.5,0.33,0.29,0.55,0.58,0.25" y="551.3" x="98.1,102.6,108.1,113.6,116.3,118.9,123.0,127.6,130.6,133.2,138.2,143.4,146.1,148.8,154.0,156.7,159.7,165.0,169.3,172.0,174.6,179.8,182.1,187.1,189.7,192.7,196.0,201.0,203.5,209.0,212.5,216.9,222.5,225.1,229.2,232.2,234.8,239.8,245.0,247.7,252.7,255.7,258.4,262.3,267.3,270.0,275.2,277.9,281.8,286.2,291.5,295.4,298.0,301.0,303.7,308.3,312.8,315.8,318.5,323.5,328.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">application in the in vitro prediction of skin sensitization.</text>
  <text svgx:width="0.67,0.44,0.56,0.33,0.44,0.41,0.33,0.55,0.78,0.39,0.39,0.78,0.44,0.33,0.25" y="551.3" x="334.9,341.0,345.1,350.2,353.2,357.3,361.0,364.0,366.7,373.8,377.3,380.9,388.0,392.1,395.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Contact Dermat.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="551.3" x="401.2,405.7,410.2,414.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005</text>
  <text svgx:width="0.25" y="551.3" x="419.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="551.3" x="424.2,428.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">53</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="551.3" x="433.3,435.5,438.3,442.9,447.4,452.0,456.6,461.1,465.7,470.3,472.5,476.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 189–200. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="551.3" x="479.5,486.0,489.4,494.4,498.3,502.2,508.3,512.7" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="551.3" x="515.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.33" y="564.3" x="98.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">[</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="564.3" x="101.0,106.5,111.9,116.8,125.3,129.6" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="564.3" x="135.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.61,0.29,0.29,0.29,0.5,0.25,0.55,0.78,0.25,0.67,0.25,0.25,0.55,0.76,0.6,0.44,0.44,0.29,0.55,0.58,0.48,0.25,0.55,0.71,0.25,0.25,0.55,0.34,0.42,0.5,0.44,0.44,0.58,0.29,0.25,0.55,0.61,0.25,0.25,0.55,0.67,0.29,0.56,0.58,0.48,0.42,0.44,0.58,0.29,0.25,0.55,0.71,0.25,0.25,0.55,0.56,0.29,0.4,0.48,0.58,0.5,0.6,0.55,0.29,0.29,0.25,0.55,0.56,0.25,0.25,0.55,0.61,0.48,0.4,0.56,0.55,0.58,0.5,0.29,0.25,0.55,0.95,0.25,0.71,0.25,0.55,0.61,0.42,0.42,0.48,0.58,0.33,0.29,0.5,0.29,0.55,0.55,0.29,0.29,0.42,0.55,0.29,0.55,0.5,0.61,0.48,0.61" y="577.2" x="76.5,81.0,85.5,87.7,98.1,103.6,106.3,109.0,111.6,116.2,118.4,121.7,128.8,131.1,137.2,139.5,141.7,145.5,152.5,158.0,162.1,166.1,168.8,173.8,179.1,183.5,185.7,189.0,195.5,197.8,200.0,203.8,206.8,210.7,215.3,219.4,223.4,228.7,231.4,233.6,236.9,242.5,244.8,247.0,250.8,256.9,259.5,264.6,270.0,274.3,278.2,282.3,287.6,290.3,292.5,295.8,302.2,304.5,306.8,310.5,315.6,318.3,321.7,326.1,331.4,336.0,341.5,346.5,349.2,351.8,354.1,357.4,361.6,363.9,366.1,369.9,375.5,379.9,383.3,388.4,393.4,398.7,403.3,406.0,408.2,411.5,420.1,422.4,428.9,431.1,434.4,440.0,443.9,447.7,452.1,457.4,460.4,463.1,467.7,470.3,473.5,478.5,481.2,483.9,487.6,491.0,493.6,498.6,503.2,508.8,513.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">11. Bilia, A.R.; Guccione, C.; Isacchi, B.; Righeschi, C.; Firenzuoli, F.; Bergonzi, M.C. Essential oils loaded</text>
  <text svgx:width="0.29,0.58,0.55,0.58,0.5,0.58,0.55,0.42,0.56,0.42,0.33,0.48,0.88,0.42,0.25,0.55,0.78,0.55,0.61,0.48,0.56,0.48,0.29,0.55,0.6,0.29,0.58,0.56,0.55,0.42,0.33,0.4,0.5,0.33,0.48,0.56,0.56,0.55,0.33,0.55,0.4,0.55,0.5,0.55,0.42,0.6,0.44,0.44,0.48,0.42,0.42,0.33,0.6,0.29,0.55,0.33,0.58,0.48,0.4,0.5,0.6,0.48,0.6,0.33,0.29,0.44,0.55,0.5,0.6,0.6,0.4,0.55,0.5,0.44,0.58,0.25" y="590.1" x="98.1,100.7,105.9,109.0,114.3,118.9,124.2,129.2,133.1,138.2,142.0,145.0,149.4,157.5,161.3,163.6,167.8,174.8,177.9,183.5,187.9,193.0,197.4,200.1,205.1,210.6,213.2,218.5,223.6,226.6,230.4,233.4,237.0,241.6,244.6,249.0,254.1,259.1,262.1,265.1,270.1,273.7,276.7,281.2,284.2,288.1,293.6,297.7,301.7,306.1,310.0,313.9,316.9,322.4,325.0,328.0,331.0,336.3,340.7,344.3,348.9,354.4,358.8,364.3,367.3,369.9,373.9,376.9,381.5,387.0,392.5,396.0,400.9,405.5,409.6,414.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in nanosystems: A developing strategy for a successful therapeutic approach.</text>
  <text svgx:width="0.61,0.5,0.28,0.5,0.25,0.55,0.61,0.44,0.39,0.39,0.5,0.55,0.67,0.44,0.78,0.5,0.28,0.39,0.78,0.39,0.56,0.33,0.25" y="590.1" x="422.1,427.7,432.2,434.8,439.4,441.6,446.5,452.1,456.2,459.7,463.3,467.8,470.8,476.9,481.0,488.1,492.7,495.2,498.8,505.9,509.4,514.5,517.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Evid. Based Complement.</text>
  <text svgx:width="0.72,0.28,0.33,0.39,0.39,0.56,0.25,0.55,0.94,0.39,0.5,0.25" y="603.0" x="97.7,104.2,106.7,109.7,113.2,116.7,121.6,123.9,126.1,134.6,138.1,142.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Altern. Med.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="603.0" x="147.6,152.1,156.5,161.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2014</text>
  <text svgx:width="0.25" y="603.0" x="165.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="603.0" x="170.0,174.5,179.0,183.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2014</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="603.0" x="187.9,190.2,192.4,196.9,201.4,205.9,210.3,214.8,219.3,221.6,224.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 651593. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="603.0" x="227.3,233.7,237.1,242.0,245.8,249.6,255.5,259.8" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33,0.55,0.33" y="603.0" x="262.8,265.8,268.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">] [</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="603.0" x="271.0,276.5,281.9,286.8,295.3,299.6" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="603.0" x="305.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.95,0.6,0.29,0.29,0.48,0.4,0.25,0.55,0.67,0.25,0.83,0.25,0.25,0.55,0.95,0.5,0.61,0.48,0.4,0.25,0.55,0.73,0.25,0.25,0.55,0.76,0.55,0.58,0.29,0.5,0.25,0.55,0.52,0.25,0.55,0.52,0.55,0.29,0.29,0.61,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.55,0.33,0.52,0.61,0.83,0.33,0.55,0.33,0.55,0.4,0.55,0.44,0.55,0.58,0.33,0.4,0.55,0.29,0.29,0.48,0.61,0.55,0.61,0.4,0.6,0.56,0.55,0.61,0.48,0.29,0.29,0.56,0.48,0.4,0.56,1.0,0.78,0.55,0.4,0.48,0.56,0.29,0.48,0.83,0.55,0.33" y="615.9" x="76.5,81.0,85.5,87.7,98.1,106.4,111.8,114.4,116.9,121.2,124.0,126.2,128.5,134.4,136.6,144.0,146.2,148.4,150.7,159.0,163.5,168.9,173.1,176.0,178.2,180.4,186.8,189.1,191.3,193.5,200.3,205.1,210.3,212.9,217.3,219.5,221.7,226.4,228.6,230.9,235.5,240.3,242.9,245.5,251.0,253.2,255.7,258.3,263.6,266.2,271.7,273.9,279.0,283.5,288.6,293.4,298.8,303.2,306.7,309.6,312.2,316.1,318.7,322.9,326.7,328.9,331.9,336.5,341.9,349.3,352.3,354.5,357.4,362.3,365.9,368.0,372.0,376.8,382.0,384.8,388.2,393.0,395.6,398.2,402.4,407.9,410.1,415.5,418.9,424.3,429.3,431.4,436.8,441.1,443.7,446.2,451.3,455.5,459.0,463.9,472.8,479.8,481.9,485.3,489.5,494.5,497.1,501.3,511.0,515.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">12. Müller, R.H.; Mäder, K.; Gohla, S. Solid lipid nanoparticles (SLN) for controlled drug delivery—A reviewof</text>
  <text svgx:width="0.33,0.58,0.48,0.55,0.42,0.33,0.5,0.33,0.48,0.55,0.55,0.33,0.55,0.33,0.58,0.48,0.55,0.5,0.4,0.33,0.25" y="628.8" x="98.1,101.0,106.2,110.5,112.7,116.5,119.5,123.9,126.9,131.2,133.4,138.3,141.3,143.5,146.4,151.7,156.0,158.2,162.7,166.2,169.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the state of the art.</text>
  <text svgx:width="0.61,0.56,0.39,0.25,0.55,0.33,0.25,0.55,0.61,0.5,0.44,0.39,0.78,0.25,0.55,0.61,0.28,0.44,0.5,0.5,0.44,0.39,0.78,0.25" y="628.8" x="174.2,179.6,184.6,187.5,189.7,192.5,195.5,197.7,199.9,205.4,209.9,213.9,217.4,224.4,226.6,229.4,234.9,237.3,241.3,245.8,250.3,254.3,257.8,264.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Eur. J. Pharm. Biopharm.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="628.8" x="269.8,274.2,278.7,283.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2000</text>
  <text svgx:width="0.25" y="628.8" x="287.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="628.8" x="292.2,296.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">50</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="628.8" x="301.1,303.4,305.6,310.1,314.6,319.1,323.6,328.0,332.5,337.0,339.2,342.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 161–177. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="628.8" x="345.0,351.4,354.7,359.6,363.4,367.2,373.2,377.5" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="628.8" x="380.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.83,0.5,0.29,0.4,0.25,0.55,0.67,0.25,0.25,0.55,0.78,0.4,0.6,0.58,0.55,0.73,0.6,0.88,0.5,0.4,0.25,0.55,0.73,0.25,0.52,0.25,0.25,0.55,0.72,0.29,0.42,0.58,0.58,0.6,0.55,0.6,0.4,0.29,0.56,0.5,0.25,0.55,0.73,0.25,0.25,0.55,0.52,0.48,0.56,0.6,0.56,0.5,0.4,0.5,0.23,0.5,0.58,0.25,0.55,0.95,0.25,0.55,0.67,0.48,0.44,0.48,0.58,0.33,0.55,0.5,0.61,0.56,0.5,0.58,0.44,0.48,0.42,0.55,0.29,0.58,0.55,0.42,0.55,0.29,0.29,0.61,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48" y="641.7" x="76.5,81.0,85.5,87.7,98.1,105.6,110.2,112.8,115.7,118.0,120.2,126.3,128.6,130.8,133.1,140.2,143.7,149.2,154.4,156.7,163.3,168.8,176.8,181.3,184.3,186.5,188.8,195.4,197.6,202.4,204.7,206.9,209.2,215.3,217.9,221.8,227.0,232.3,237.7,240.0,245.5,249.1,251.8,256.8,261.4,263.6,265.9,272.5,274.8,277.0,279.3,284.0,288.4,293.5,299.0,304.1,308.6,312.2,316.7,318.9,323.4,328.7,330.9,333.2,341.8,344.0,346.3,352.4,356.7,360.8,365.1,370.4,373.4,375.6,380.2,385.7,390.8,395.4,400.7,404.7,409.1,412.8,415.2,417.8,423.0,425.3,429.2,434.1,436.8,439.4,444.9,447.2,449.9,452.5,458.0,460.6,466.1,468.4,473.7,478.2,483.5,488.5,494.0,498.5,502.1,505.1,507.7,511.7,514.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">13. Nair, R.; Arun Kumar, K.S.; Vishnu Priya, K.; Sevukarajan, M. Recent advances in solid lipid nanoparticle</text>
  <text svgx:width="0.55,0.5,0.42,0.48,0.61,0.55,0.61,0.4,0.6,0.56,0.55,0.61,0.48,0.29,0.29,0.56,0.48,0.4,0.56,0.55,0.42,0.56,0.42,0.33,0.48,0.88,0.42,0.25" y="654.6" x="98.1,103.0,107.5,111.3,115.6,121.1,123.3,128.8,132.3,137.7,142.7,144.9,150.4,154.7,157.3,159.9,164.9,169.2,172.8,177.8,180.0,183.8,188.8,192.6,195.5,199.8,207.7,211.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">based drug delivery systems.</text>
  <text svgx:width="0.33,0.25,0.55,0.61,0.28,0.44,0.78,0.39,0.5,0.25,0.55,0.56,0.41,0.28,0.25,0.55,0.67,0.39,0.39,0.25" y="654.6" x="216.6,219.5,221.8,224.0,229.5,232.0,236.0,243.0,246.4,250.9,253.2,255.9,260.9,264.6,267.1,269.3,272.1,278.1,281.6,285.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">J. Biomed. Sci. Res.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="654.6" x="290.1,294.6,299.0,303.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2011</text>
  <text svgx:width="0.25" y="654.6" x="308.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5" y="654.6" x="312.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">3</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25" y="654.6" x="317.0,319.2,321.5,325.9,330.4,334.9,339.4,343.9,348.4,352.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 368–384.</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.52,0.29,0.58,0.56,0.58,0.5,0.29,0.25,0.55,0.76,0.25,0.61,0.25,0.25,0.55,0.6,0.5,0.33,0.48,0.29,0.25,0.55,0.67,0.25,0.6,0.25,0.25,0.55,0.6,0.4,0.5,0.23,0.5,0.6,0.5,0.33,0.29,0.25,0.55,0.61,0.25,0.76,0.25,0.25,0.55,0.6,0.5,0.33,0.48,0.29,0.25,0.55,0.83,0.25,0.78,0.25,0.55,0.52,0.55,0.29,0.29,0.61,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.55,0.5,0.58,0.61,0.55,0.58,0.5,0.58,0.55,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.44,0.5,0.4,0.4,0.29,0.48,0.4,0.42,0.25,0.55,0.78,0.42,0.55,0.58,0.55,0.56,0.48,0.29" y="667.5" x="76.5,81.0,85.5,87.7,98.1,102.7,105.2,110.3,115.2,120.3,124.7,127.3,129.5,131.3,138.0,140.2,145.6,147.8,150.0,151.9,157.2,161.6,164.5,168.7,171.2,173.5,175.2,181.1,183.3,187.4,189.6,191.9,193.8,199.1,202.6,206.9,209.0,213.4,218.7,223.1,225.9,228.5,230.7,232.5,237.9,240.1,246.8,249.0,251.2,253.1,258.4,262.8,265.7,269.9,272.4,274.7,276.4,283.7,285.9,292.8,295.0,296.8,301.4,306.2,308.7,311.3,316.8,318.5,321.0,323.6,328.9,331.4,336.9,338.6,343.7,348.1,353.2,358.0,363.3,367.7,371.1,374.0,376.6,380.5,383.0,387.2,391.0,392.8,397.2,402.3,407.7,409.4,414.6,418.9,424.1,429.0,430.7,433.2,435.8,441.1,443.6,449.1,450.8,454.7,459.1,462.5,466.0,468.6,472.8,476.3,480.0,482.2,484.7,491.6,495.3,497.1,502.2,507.0,512.0,516.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">14. Singhal, G.B.; Patel, R.P.; Prajapati, B.G.; Patel, N.A. Solid lipid nanoparticles and nano lipid carriers: As novel</text>
  <text svgx:width="0.42,0.55,0.29,0.29,0.61,0.55,0.29,0.29,0.6,0.29,0.61,0.55,0.55,0.5,0.42,0.48,0.61,0.55,0.61,0.4,0.6,0.56,0.55,0.44,0.5,0.4,0.4,0.29,0.48,0.4,0.25" y="680.5" x="98.1,101.9,106.7,109.4,112.0,117.4,119.7,122.3,124.9,130.3,132.9,138.4,140.6,145.6,150.1,153.9,158.2,163.6,165.9,171.4,174.8,180.2,185.3,187.5,191.4,195.9,199.5,203.0,205.6,209.9,212.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">solid lipid based drug carrier.</text>
  <text svgx:width="0.33,0.67,0.33,0.61" y="680.5" x="217.8,220.8,226.8,229.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">IRJP</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="680.5" x="237.5,242.0,246.5,250.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2011</text>
  <text svgx:width="0.25" y="680.5" x="255.4" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5" y="680.5" x="259.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.25" y="680.5" x="264.4,266.6,268.9,273.4,277.8,282.3,286.8,291.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 40–52.</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.52,0.55,0.6,0.33,0.55,0.25,0.55,0.61,0.25,0.61,0.25,0.25,0.55,0.95,0.6,0.29,0.29,0.48,0.4,0.25,0.55,0.67,0.25,0.83,0.25,0.55,0.61,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.25,0.55,0.61,0.33,0.33,0.48,0.44,0.33,0.55,0.55,0.58,0.55,0.55,0.29,0.55,0.5,0.56,0.5,0.29,0.29,0.5,0.55,0.29,0.29,0.29,0.33,0.56,0.55,0.5,0.58,0.61,0.55,0.6,0.58,0.5,0.4,0.88,0.5,0.44,0.55,0.56,0.29,0.58,0.48,0.33,0.29,0.44,0.55,0.44,0.58,0.5,0.58,0.56,0.48,0.42,0.25" y="693.4" x="76.5,81.0,85.5,87.7,98.1,102.9,107.8,113.4,116.3,121.3,123.6,127.3,132.9,135.2,140.7,143.0,145.3,149.7,158.3,163.9,166.5,169.2,173.6,176.5,178.7,182.4,188.6,190.8,198.5,200.7,204.4,210.0,212.7,218.2,220.8,226.3,230.1,235.4,240.0,245.3,250.3,255.8,260.3,264.0,266.9,269.6,273.7,276.3,280.7,284.6,286.8,292.5,298.1,300.9,304.0,308.4,312.4,315.4,319.1,324.1,329.3,333.1,338.1,340.8,345.8,350.3,355.5,360.1,362.7,365.4,370.0,375.0,377.7,380.4,383.0,386.0,391.0,394.7,399.3,404.6,410.1,413.9,419.4,424.7,429.3,432.9,441.0,445.5,449.6,454.6,459.7,462.3,467.7,472.0,475.0,477.7,481.6,485.4,489.5,494.8,499.4,504.7,509.8,514.1,518.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">15. Souto, E.B.; Müller, R.H. Lipid nanoparticles: Effect on bioavailability and pharmacokinetic changes.</text>
  <text svgx:width="0.78,0.44,0.56,0.5,0.46,0.25,0.55,0.61,0.5,0.5,0.25,0.55,0.61,0.5,0.44,0.39,0.78,0.44,0.41,0.44,0.28,0.25" y="706.3" x="97.7,104.7,108.7,113.6,118.1,122.3,124.5,126.8,132.2,136.7,141.2,143.4,145.7,151.2,155.7,159.6,163.1,170.1,174.1,177.7,181.7,184.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Handb. Exp. Pharmacol.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="706.3" x="189.2,193.7,198.2,202.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2010</text>
  <text svgx:width="0.25" y="706.3" x="207.2" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5,0.5" y="706.3" x="211.6,216.1,220.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">197</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="706.3" x="225.1,227.3,229.6,234.1,238.5,243.0,247.5,252.0,256.5,261.0,263.2,266.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 115–141. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="706.3" x="269.0,275.3,278.7,283.6,287.4,291.2,297.2,301.5" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="706.3" x="304.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.52,0.44,0.58,0.5,0.33,0.48,0.4,0.33,0.73,0.55,0.4,0.33,0.29,0.58,0.56,0.25,0.55,0.95,0.25,0.25,0.55,0.95,0.48,0.58,0.58,0.48,0.4,0.33,0.25,0.55,1.0,0.25,0.25,0.55,0.73,0.55,0.4,0.33,0.29,0.58,0.56,0.25,0.55,0.83,0.25,0.71,0.25,0.55,0.61,0.29,0.6,0.29,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.55,0.33,0.55,0.4,0.55,0.29,0.88,0.6,0.4,0.55,0.56,0.48,0.61,0.55,0.33,0.55,0.6,0.29,0.44,0.5,0.29,0.55,0.5,0.6,0.6,0.29,0.29,0.44,0.5,0.33,0.29,0.55,0.58,0.55,0.55,0.33" y="719.2" x="76.5,81.0,85.5,87.7,98.1,102.9,106.9,112.2,116.8,119.9,124.2,127.7,130.7,137.4,142.4,146.0,149.0,151.6,156.9,162.0,164.3,166.8,175.5,177.7,180.0,182.7,191.3,195.7,201.0,206.3,210.7,214.3,217.3,219.6,222.1,230.4,232.7,234.9,237.6,244.2,249.2,252.9,255.8,258.5,263.8,268.9,271.1,273.7,281.3,283.6,290.1,292.3,294.8,300.4,303.1,308.6,311.3,316.7,319.3,324.7,329.2,334.5,339.5,345.0,349.6,353.2,356.2,358.9,362.9,365.6,370.0,373.7,376.3,379.4,384.4,388.0,390.5,393.2,401.2,406.7,410.2,415.2,420.3,424.7,430.2,432.8,435.8,440.8,446.3,448.9,453.0,457.6,460.2,462.7,467.3,472.8,478.3,481.0,483.6,487.7,492.2,495.2,497.9,502.9,508.1,510.7,515.7" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">16. Schäfer-Korting, M.; Mehnert, W.; Korting, H.C. Lipid nanoparticles for improved topical application of</text>
  <text svgx:width="0.61,0.4,0.6,0.56,0.42,0.55,0.33,0.55,0.4,0.55,0.42,0.56,0.29,0.58,0.55,0.61,0.29,0.42,0.48,0.5,0.42,0.48,0.42,0.25" y="732.1" x="98.1,103.5,107.0,112.4,117.4,121.2,123.4,126.4,131.3,134.9,137.1,140.9,145.9,148.5,153.7,156.0,161.4,164.0,167.8,172.1,176.6,180.4,184.7,188.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">drugs for skin diseases.</text>
  <text svgx:width="0.72,0.5,0.5,0.25,0.55,0.78,0.39,0.56,0.5,0.55,0.78,0.39,0.28,0.28,0.5,0.25,0.55,0.67,0.39,0.5,0.25" y="732.1" x="193.5,200.0,204.5,208.5,210.7,213.5,220.5,224.0,229.0,233.4,235.7,242.7,246.1,248.6,251.1,255.1,257.4,260.1,266.1,269.6,273.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Adv. Drug Deliv. Rev.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="732.1" x="278.6,283.1,287.6,292.1" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2007</text>
  <text svgx:width="0.25" y="732.1" x="296.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="732.1" x="301.0,305.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">59</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="732.1" x="310.0,312.2,314.5,319.0,323.5,327.9,332.4,336.9,341.4,345.9,348.1,350.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 427–443. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="732.1" x="353.9,360.2,363.6,368.5,372.3,376.1,382.1,386.4" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33,0.55,0.33" y="732.1" x="389.4,392.3,394.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">] [</text>
  <text svgx:width="0.6,0.6,0.55,0.95,0.48,0.61" y="732.1" x="397.6,403.0,408.4,413.4,421.9,426.2" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PubMed</text>
  <text svgx:width="0.33" y="732.1" x="431.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
  <text svgx:width="0.5,0.5,0.25,0.55,0.95,0.55,0.58,0.33,0.48,0.58,0.48,0.56,0.4,0.55,0.25,0.55,0.61,0.25,0.55,0.61,0.29,0.6,0.29,0.61,0.33,0.55,0.5,0.42,0.48,0.61,0.55,0.58,0.5,0.58,0.55,0.6,0.5,0.4,0.33,0.29,0.44,0.29,0.48,0.42,0.55,0.5,0.42,0.55,0.44,0.5,0.4,0.4,0.29,0.48,0.4,0.42,0.55,0.33,0.55,0.4,0.55,0.61,0.48,0.4,0.88,0.5,0.29,0.55,0.61,0.48,0.29,0.29,0.56,0.48,0.4,0.56,0.55,0.55,0.33,0.55,0.5,0.58,0.33,0.29,0.55,0.52,0.29,0.61,0.5,0.58,0.33,0.42,0.25" y="745.0" x="76.5,81.0,85.5,87.7,98.1,106.5,111.3,116.5,119.4,123.7,128.9,133.1,138.1,141.4,146.3,148.5,150.8,156.2,158.4,160.7,166.1,168.7,174.0,176.6,182.1,185.0,190.0,194.4,198.2,202.5,207.9,210.1,215.3,219.8,224.9,229.8,235.2,239.6,243.1,246.0,248.6,252.6,255.2,259.4,263.2,265.4,269.9,273.7,275.9,279.9,284.3,287.8,291.3,293.9,298.2,301.7,305.5,307.7,310.7,315.5,319.1,321.3,326.7,331.0,334.5,342.4,346.8,349.4,351.7,357.1,361.4,364.0,366.6,371.6,375.9,379.4,384.4,386.6,391.4,394.4,396.6,401.1,406.2,409.2,411.7,416.6,421.2,423.8,429.2,433.7,438.9,441.8,445.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">17. Montenegro, L. Lipid-based nanoparticles as carriers for dermal delivery of antioxidants.</text>
  <text svgx:width="0.67,0.56,0.39,0.39,0.25,0.55,0.78,0.39,0.56,0.5,0.55,0.94,0.39,0.33,0.44,0.46,0.25" y="745.0" x="450.5,456.5,461.4,464.9,467.7,469.9,472.7,479.6,483.1,488.0,492.5,494.7,503.1,506.6,509.6,513.5,517.6" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Curr. Drug Metab.</text>
  <text svgx:width="0.5,0.5,0.5,0.5" y="757.9" x="98.1,102.5,107.0,111.5" style="fill:rgb(0,0,0);font-family:URWPalladioL-Bold;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2017</text>
  <text svgx:width="0.25" y="757.9" x="116.0" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.5,0.5" y="757.9" x="120.5,124.9" style="fill:rgb(0,0,0);font-family:URWPalladioL-Ital;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">18</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33" y="757.9" x="129.4,131.7,133.9,138.4,142.9,147.4,151.8,156.3,160.8,165.3,167.5,170.3" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, 469–480. [</text>
  <text svgx:width="0.71,0.4,0.55,0.42,0.42,0.67,0.48,0.33" y="757.9" x="173.3,179.7,183.0,187.9,191.7,195.5,201.5,205.8" style="fill:rgb(8,117,183);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">CrossRef</text>
  <text svgx:width="0.33" y="757.9" x="208.8" style="fill:rgb(0,0,0);font-family:URWPalladioL-Roma;font-size:9.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">]</text>
 </g>
</svg>
